Ines Kaupe

1.6k total citations · 1 hit paper
13 papers, 1.2k citations indexed

About

Ines Kaupe is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Ines Kaupe has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in Ines Kaupe's work include Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Eosinophilic Disorders and Syndromes (7 papers). Ines Kaupe is often cited by papers focused on Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Eosinophilic Disorders and Syndromes (7 papers). Ines Kaupe collaborates with scholars based in Austria, United States and Canada. Ines Kaupe's co-authors include Giulio Superti‐Furga, Oliver Hantschel, Keiryn L. Bennett, Jacques Colinge, Melanie Planyavsky, Thomas Köcher, Peter Valent, Gerhard Dürnberger, Lily L. Remsing Rix and Uwe Rix and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Ines Kaupe

13 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

2007 532 citations Uwe Rix, Oliver Hantschel et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ines Kaupe Austria	10	594	583	411	236	218	13	1.2k
Janis Liebetanz Switzerland	10	976 1.6×	402 0.7×	270 0.7×	157 0.7×	392 1.8×	11	1.6k
M. Gorre United States	15	443 0.7×	551 0.9×	504 1.2×	285 1.2×	286 1.3×	28	1.3k
Chester A. Metcalf United States	19	648 1.1×	294 0.5×	198 0.5×	149 0.6×	353 1.6×	29	1.2k
David Wisniewski United States	22	859 1.4×	697 1.2×	435 1.1×	203 0.9×	311 1.4×	44	1.6k
Mohammad Azam United States	18	694 1.2×	856 1.5×	664 1.6×	363 1.5×	318 1.5×	36	1.6k
Ryan P. Million United States	11	340 0.6×	503 0.9×	298 0.7×	163 0.7×	193 0.9×	15	944
Derek Norris United States	14	469 0.8×	1.0k 1.8×	738 1.8×	497 2.1×	316 1.4×	19	1.7k
Ophelia Rogers United States	14	697 1.2×	397 0.7×	503 1.2×	216 0.9×	129 0.6×	33	1.2k
Francis Y. F. Lee United States	15	586 1.0×	578 1.0×	393 1.0×	223 0.9×	866 4.0×	16	1.8k
Maeva Dufies France	25	734 1.2×	185 0.3×	133 0.3×	91 0.4×	388 1.8×	46	1.5k

Countries citing papers authored by Ines Kaupe

Since Specialization

Citations

This map shows the geographic impact of Ines Kaupe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Kaupe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Kaupe more than expected).

Fields of papers citing papers by Ines Kaupe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ines Kaupe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Kaupe. The network helps show where Ines Kaupe may publish in the future.

Co-authorship network of co-authors of Ines Kaupe

This figure shows the co-authorship network connecting the top 25 collaborators of Ines Kaupe. A scholar is included among the top collaborators of Ines Kaupe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ines Kaupe. Ines Kaupe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Dürnberger, Gerhard, Tilmann Bürckstümmer, K. Huber, et al.. (2013). Experimental characterization of the human non-sequence-specific nucleic acid interactome. Genome biology. 14(7). R81–R81. 6 indexed citations

2.

Hantschel, Oliver, Wolfgang Warsch, Eva Eckelhart, et al.. (2012). BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Nature Chemical Biology. 8(3). 285–293. 131 indexed citations

3.

Burkard, Thomas R., Melanie Planyavsky, Ines Kaupe, et al.. (2011). Initial characterization of the human central proteome. BMC Systems Biology. 5(1). 17–17. 60 indexed citations

4.

Grebien, Florian, Oliver Hantschel, John Wojcik, et al.. (2011). Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis. Cell. 147(2). 306–319. 107 indexed citations

5.

Wojcik, John, Oliver Hantschel, Florian Grebien, et al.. (2010). A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nature Structural & Molecular Biology. 17(4). 519–527. 128 indexed citations

6.

Sherbenou, Daniel W., Oliver Hantschel, Ines Kaupe, et al.. (2010). BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib. Blood. 116(17). 3278–3285. 63 indexed citations

7.

Kaupe, Ines, et al.. (2009). Signal transduction and metabolism in chondrocytes is modulated by lactoferrin. Osteoarthritis and Cartilage. 18(1). 117–125. 33 indexed citations

8.

Brehme, Marc, Oliver Hantschel, Jacques Colinge, et al.. (2009). Charting the molecular network of the drug target Bcr-Abl. Proceedings of the National Academy of Sciences. 106(18). 7414–7419. 126 indexed citations

9.

Hantschel, Oliver, Florian Grebien, Ines Kaupe, et al.. (2009). The Bcr-Abl SH2-Kinase Domain Interface Is Critical for Leukemogenesis and An Additional Therapeutic Target in CML.. Blood. 114(22). 37–37. 1 indexed citations

10.

Sherbenou, Daniel W., Oliver Hantschel, Ines Kaupe, et al.. (2008). Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia. Leukemia. 22(6). 1184–1190. 31 indexed citations

11.

Hantschel, Oliver, Jacques Colinge, Ines Kaupe, et al.. (2008). The chemokine interleukin‐8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia. Molecular Oncology. 2(3). 272–281. 26 indexed citations

12.

Hantschel, Oliver, Uwe Rix, Uwe Schmidt, et al.. (2007). Systematic Profiling and Novel Targets of the Bcr-Abl Kinase Inhibitors Imatinib, Nilotinib and Dasatinib.. Blood. 110(11). 4542–4542. 1 indexed citations

13.

Rix, Uwe, Oliver Hantschel, Gerhard Dürnberger, et al.. (2007). Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood. 110(12). 4055–4063. 532 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact